TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 388,250 | 305,650 | 306,969 |
Financial expenses | 1,296 | 1,052 | 1,048 |
Earnings before taxes | 60,255 | 29,262 | 27,035 |
EBITDA | 77,836 | 43,255 | 37,567 |
Total assets | 326,949 | 283,668 | 217,546 |
Current assets | 168,267 | 134,408 | 137,562 |
Current liabilities | 79,819 | 53,186 | 59,551 |
Equity capital | 169,669 | 130,807 | 117,435 |
- share capital | 27,541 | 27,541 | 27,541 |
Employees (average) | 212 | 184 | 175 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 51.9% | 46.1% | 54.0% |
Turnover per employee | 1,831 | 1,661 | 1,754 |
Profit as a percentage of turnover | 15.5% | 9.6% | 8.8% |
Return on assets (ROA) | 18.8% | 10.7% | 12.9% |
Current ratio | 210.8% | 252.7% | 231.0% |
Return on equity (ROE) | 35.5% | 22.4% | 23.0% |
Change turnover | 82,600 | -1,319 | -8,937 |
Change turnover % | 27% | 0% | -3% |
Chg. No. of employees | 28 | 9 | 4 |
Chg. No. of employees % | 15% | 5% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.